IM Cannabis Corp. announced it has regained compliance with Nasdaq's minimum bid price rule after its share price stayed at or above $1.00 for 18 consecutive business days. This compliance removes the risk of delisting from Nasdaq. The company operates medical cannabis businesses in Israel and Germany, with plans to retain Israeli operations and sell the German ones. This development stabilizes IM Cannabis's listing status and supports its ongoing business strategy.
IM Cannabis's Nasdaq compliance update is offered here with Pluang's health sector snapshot. Of 100 health-sector US stocks on Pluang, 10 rose and 89 fell today. TXG traded at USD 75.08 with a 1-day change of -6.96%, CLPT was at USD 14.72 down 6.78%, and AMLX closed at USD 30.78 down 6.73% as of Sep 24, 2026 02:11 WIB.
Jefferies reaffirmed its Buy rating on Life Time Group Holdings (LTH), citing a positive earnings outlook supported by a Zacks Rank of #2. The stock trades around $38.85 with a market cap near $8.68 billion. Despite this optimism, Executive Vice Pres...
Jefferies analysts set a new price target of $435 for General Electric Aerospace, implying a 35% upside from its current price of around $321. GE Aerospace's strong position is supported by a $170 billion commercial services backlog and 80,000 aircra...
BNP Paribas lowered its price target for PepsiCo from $183 to $161 on September 23, 2026, due to ongoing demand challenges in North America. Despite the cut, the firm maintained an Outperform rating, indicating confidence in the stock's potential. Th...
Berkshire Hathaway has acquired more than a 10% stake in Lennar, a homebuilder facing challenges like rising mortgage rates and a recent earnings miss. Lennar's CEO noted that nearly half of potential buyers can't qualify for mortgages, and the compa...
Medtronic began fiscal year 2027 with strong first-quarter results, exceeding expectations with 7% normalized revenue growth driven by its Cardiovascular and Neuroscience segments. The company raised its revenue and earnings per share guidance, altho...
